MDxHealth SA provided revenue guidance for the Full year 2022. For the Year, Company expects revenue of $25 million to $27 million, representing growth of 13% to 21% over full year 2021 revenue of $22.2 million.
MDxHealth SA Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.40% | 41.35B | |
+41.93% | 40.38B | |
+3.66% | 39.05B | |
-12.11% | 26.67B | |
+2.12% | 24.07B | |
-23.70% | 18.36B | |
-3.37% | 11.68B | |
+21.55% | 11.6B | |
+7.99% | 11.15B |